Bleeding in renal failure.
D000740:Anemia / Q000097:blood / Q000150:complications; D001241:Aspirin / Q000009:adverse effects; D001760:Bleeding Time; D001792:Blood Platelets / Q000187:drug effects / Q000378:metabolism; D001803:Blood Transfusion; D003451:Cryoprotective Agents / Q000627:therapeutic use; D003894:Deamino Arginine Vasopressin / Q000627:therapeutic use; D017707:Erythrocyte Transfusion; D004921:Erythropoietin / Q000627:therapeutic use; D004967:Estrogens / Q000627:therapeutic use; D006470:Hemorrhage / Q000097:blood / Q000150:complications / Q000188:drug therapy / Q000209:etiology* / Q000378:metabolism; D006801:Humans; D010281:Parathyroid Hormone / Q000502:physiology; D010973:Platelet Adhesiveness / Q000187:drug effects; D010974:Platelet Aggregation; D013928:Thromboxane A2 / Q000378:metabolism; D014511:Uremia / Q000097:blood / Q000150:complications* / Q000628:therapy; D014841:von Willebrand Factor / Q000502:physiology
D003451:Cryoprotective Agents; D004967:Estrogens; D010281:Parathyroid Hormone; D014841:von Willebrand Factor; D004921:Erythropoietin; D013928:Thromboxane A2; D003894:Deamino Arginine Vasopressin; D001241:Aspirin